|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 07 Sep 2024 | Reference Range | Unit |
|---|---|---|---|
| Cholesterol [Mass/volume] in Serum or Plasma | 190.3 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 146.3 | 35 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 97.1 | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 63.9 | 40 - 100 | mg/dL |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| Lipid profile is within target range and stable over time. Hematology shows elevated hemoglobin with low hematocrit, which may suggest hemoconcentration or possible lab artifact; other red cell indices are normal. Platelet count is normal, but platelet distribution width is markedly elevated, which may indicate increased platelet size variability—consider correlation with clinical context. No acute abnormalities detected. |